CoChat

Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?

Open access
Maciejewska, Barbara, Olszak, Tomasz, Drulis-Kawa, Zuzanna · 2018 · Applied Microbiology and Biotechnology

The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.

Abstract

Bacteriophages (phages) are viruses that infect bacteria. The "predator-prey" interactions are recognized as a potentially effective way to treat infections. Phages, as well as phage-derived proteins, especially enzymes, are intensively studied to become future alternative or supportive antibacterials used alone or in combination with standard antibiotic regimens treatment. There are many publications presenting phage therapy aspects, and some papers focused separately on the application of phage-derived enzymes. In this review, we discuss advantages and limitations of both agents concerning their specificity, mode of action, structural issues, resistance development, pharmacokinetics, product preparation, and interactions with the immune system. Finally, we describe the current regulations for phage-based product application.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00253-018-8811-1

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The possible consequences of phage infection: a bacterial host lysis and release of phage progeny; b lack of virus propagation conditioned by bacterial resistance to phage infection; c lack of host lysis and phage DNA maintenance as an episome (pseudolysogeny, lytic and temperate phages); d lack of host lysis and phage DNA integration into bacterial genome (lysogeny, temperate phages)
Fig. 1 The possible consequences of phage infection: a bacterial host lysis and release of phage progeny; b lack of virus propagation conditioned by bacterial resistance to phage infection; c lack of host lysis and phage DNA maintenance as an episome (pseudolysogeny, lytic and temperate phages); d lack of host lysis and phage DNA integration into bacterial genome (lysogeny, temperate phages)CC BY · PubMed Central
Fig. 2 The main characteristics of phage-based products application. The application of lytic phage preparation may result in both bacterial host lysis (the effect observed even in minutes) or lack of lysis (transition into a pseudolysogeny state). The application of lysin-based product leads to the lysis of targeted host (the effect observed even in seconds). The application of depolymerase-based product leads to degradation of capsule (CPS), exopolysaccharides (EPS), or lipopolysaccharides (LPS) decreasing bacterial virulence followed by enhancement of immune system clearance (the effect observed even in minutes)
Fig. 2 The main characteristics of phage-based products application. The application of lytic phage preparation may result in both bacterial host lysis (the effect observed even in minutes) or lack of lysis (transition into a pseudolysogeny state). The application of lysin-based product leads to the lysis of targeted host (the effect observed even in seconds). The application of depolymerase-based product leads to degradation of capsule (CPS), exopolysaccharides (EPS), or lipopolysaccharides (LPS) decreasing bacterial virulence followed by enhancement of immune system clearance (the effect observed even in minutes)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 250

Metadata

Authors
Maciejewska, B., Olszak, T., & Drulis-Kawa, Z.
Affiliations
University of Wrocław (PL)
Venue
Applied Microbiology and Biotechnology
Published
2018-02-13
Volume
102
Issue
6
Pages
2563-2581
ISSN
  • 0175-7598 (ISSN-L)
  • 1432-0614
OpenAlex
W2789070437
Cited by
222
References
154
Citations by year
2026: 15 · 2025: 22 · 2024: 27 · 2023: 32 · 2022: 31 · 2021: 36 · 2020: 26 · 2019: 25 · 2018: 8
FWCI
2.51
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • Applied Microbiology and Biotechnology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Narodowe Centrum Nauki (UMO-2016/21/B/NZ6/01157)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Photodynamic Therapy Research Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Keywords
bacteriophages, phage therapy, bacterial infection, phage resistance, pharmacokinetics, immune interactions, phage specificity
MeSH terms
Phage Therapy, Bacterial Infections, Bacteriophages, Enzymes, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.